Sustained release labetalol tablets

Details Sustained release labetalol tablets Sustained release labetalol tablets

1989-02-02

1990-07-10

Schofer, Joseph L.

Drug, bio-affecting and body treating compositions

Lymphokine

514166, A61K 3179, A01N 3736

Patent

active

049405802

ABSTRACT:
A sustained release dosage form of labetalol hydrochloride is disclosed comprising the active ingredient in a polymeric matrix of hydroxypropylmethylcellulose and polyvinylpyrrolidone and a pharmaceutically acceptable organic acid.

REFERENCES:
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4066755 (1978-01-01), Lunts et al.
patent: 4291015 (1981-09-01), Keith et al.
patent: 4328213 (1982-05-01), Ecker et al.

Affiliated with

Also associated with

Rating

Sustained release labetalol tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release labetalol tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release labetalol tablets will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1720063